Medication info
Simvastatin Tablets 20 mg (Simvastatin)

Simvastatin Tablets 20 mg (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Apricot-colored oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200201201 · Notified 2002.05.29 · Insurance code 640001030

Summary

Main use
Improvement of hyperlipidemia and familial hypercholesterolemia in children; prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Before starting treatment, adjust the dose as appropriate based on the initial LDL cholesterol level, treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have been taking 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), refer to the information below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this drug once daily in the evening. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or if other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is coadministered with verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering drugs This drug is effective when used alone or in combination with a bile acid sequestrant. When this drug is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients in whom the drug is contraindicated under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this drug is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg daily and monitor carefully.
Child dose
3. Use in pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia 10 ~ 17 years: The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, with a recommended maximum dose of 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia and familial hypercholesterolemia in children; prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • other cerebrovascular diseases
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication helps lower the risk of cardiovascular disease and assists in the treatment of hyperlipidemia. It is used to reduce the risk of heart attacks or strokes in adults with a history of coronary heart disease, diabetes, peripheral vascular disease, or stroke, as well as to decrease the likelihood of complications after vascular surgery. Additionally, it manages cholesterol and triglyceride levels in patients with primary hypercholesterolemia or mixed dyslipidemia, thereby improving cardiovascular health. It is also effective in individuals with genetic hyperlipidemia, such as familial hypercholesterolemia, when used alongside dietary measures. It can also be used to reduce cholesterol levels in pediatric patients aged 10 to 17 years with familial hypercholesterolemia. Overall, this medication aids in the prevention of cardiovascular disease and the improvement of lipid levels.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this drug once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this drug. A dose of 5 ~ 40 mg of this drug once daily in the evening is recommended. Before starting treatment, adjust the dose as appropriate based on the initial LDL cholesterol level, treatment goal, and the patient's response to the drug. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter, and adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this drug at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have been taking 80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) For recommended doses in patients receiving this drug concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), refer to the information below (see 6. Interactions under Precautions for Use). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this drug once daily in the evening. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or if other lipid-lowering treatments are unavailable. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this drug. (3) Use in patients receiving verapamil, diltiazem, or dronedarone When this drug is coadministered with verapamil, diltiazem, or dronedarone, the dose of this drug should not exceed 10 mg daily. (4) Use in patients receiving amiodarone, amlodipine, or ranolazine When this drug is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this drug should not exceed 20 mg daily. (5) Concomitant use with other lipid-lowering drugs This drug is effective when used alone or in combination with a bile acid sequestrant. When this drug is coadministered with a fibrate (excluding gemfibrozil (see 2. Patients in whom the drug is contraindicated under Precautions for Use) and fenofibrate), the dose of this drug should not exceed 10 mg daily. (6) Use in patients with renal impairment Because this drug is not extensively excreted by the kidneys, dose adjustment is not required in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg daily and monitor carefully.

Child dose

3. Use in pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia 10 ~ 17 years: The recommended initial dose is 10 mg of this drug once daily in the evening. The recommended dose range is 10 ~ 40 mg daily, with a recommended maximum dose of 40 mg daily. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication is primarily used to lower cholesterol levels. When taking this medication, special attention should be paid to muscle-related side effects. Muscle pain or weakness may occur, and in severe cases, a condition called rhabdomyolysis, which involves muscle tissue damage, can arise. Such side effects are more frequent with higher doses, particularly when taking 80 mg. Since this medication is metabolized in the liver, it should not be taken by patients with impaired liver function or active liver disease. Additionally, pregnant women or those who may become pregnant, as well as nursing mothers, should not use this medication. Particularly when taking other medications that interact with this drug, the risk of muscle damage may increase, so consultation with a physician is necessary. Co-administration with strong CYP3A4 inhibitors, certain antifungals, antibiotics, immunosuppressants, and some cardiac medications may require dose adjustments or changes in medication. Elderly patients, those with reduced kidney function, or patients with hypothyroidism should use this medication cautiously due to a higher risk of muscle side effects. During treatment, regular liver function tests and muscle enzyme tests are recommended. If abnormal symptoms or test results occur, immediately inform a healthcare professional. Additionally, be cautious about excessive intake of foods or beverages that inhibit the CYP3A4 enzyme, such as grapefruit juice, as this may increase the blood concentration of this medication and raise the risk of side effects. This medication should not be taken during pregnancy, and women planning to become pregnant should ensure proper contraception. It is also not recommended for nursing mothers. This medication is not to be used in children under 10 years of age or in females before menarche; in pediatric patients aged 10 to 17 years, it should be administered according to a doctor's instructions. In case of overdose, standard emergency treatments should be performed, and if symptoms arise, medical attention should be sought immediately. Finally, this medication should be stored out of reach of children and kept in its original container; transferring it to another container should be avoided.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • indigestion
  • bloating
  • nausea
  • headache
Show 83 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • extraocular muscle dysfunction
  • facial asymmetry
  • tremor
  • sensory disturbance
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorder
  • anxiety
  • sleep disorder
  • nightmare
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • hepatitis
  • liver dysfunction
  • jaundice
  • alopecia
  • pruritus
  • skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • progression of cataracts
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • increased ALP
  • elevated γ-GTP
  • increased bilirubin levels
  • thyroid dysfunction
  • increased serum creatine kinase
  • abnormal liver function tests
  • liver failure
  • pancreatitis
  • anorexia
  • vomiting
  • thrombocytopenia
  • lupus erythematosus-like syndrome
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • interstitial lung disease
  • limb sensory numbness
  • tingling sensation
  • cold sensation
  • muscle strength reduction
  • muscle weakness
  • myalgia
  • vomiting
  • mucus stools

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. By storing it in this way, the efficacy of the medication can be preserved for a longer duration.

Appearance and packaging

Appearance

Apricot-colored oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.